CIMB Research expects robust demand for the company’s US-made nitrile gloves.
PETALING JAYA: The US Centres for Medicare and Medicaid Services’ (CMS) proposal to include US-produced domestic nitrile gloves under its payment adjustment scheme from Jan 1, 2026, a decision that is expected to boost demand for US-made nitrile gloves, will benefit Supermax Corp Bhd
.
The glovemaker, which recently commissioned its US plant, is said by CIMB Research to gain from the CMS’ proposed modification to include nitrile gloves under its payment adjustment scheme under its Medicare and Medicaid programmes in which buyers would be compensated for the additional costs of purchasing domestically manufactured gloves.
